Logo Typhim Vi

TYPHIM Vi® OVERVIEW

TYPHIM Vi is indicated for active immunisation against typhoid fever caused by Salmonella enterica serovar Typhi, S.Typhi.

Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.

TYPHIM Vi Prescribing information

View the TYPHIM Vi SmPC

Why help protect your patients with TYPHIM Vi?

Typhoid fever is a bacterial infection that remains common in countries with poor sanitation and hygiene practices. Transmission usually occurs via the faecal-oral route from ingestion of contaminated food or water. Each year, globally, an estimated 20 million cases of typhoid occur and up to 161,000 deaths.1

TYPHIM Vi provides up to 3 years’ protection against typhoid fever (from day 21 after vaccination). Immunity appears within 2-3 weeks after injection.

 

Presentation

Schedule

Further doses

Age range

Logo Typhim Vi

0.5 ml prefilled syringe
Available in 1 and 10
syringe packs

1 dose

1 dose every 3 years for those at continued risk

2 years +

 

References:

  1. WHO Typhoid Fact sheet. http://www.who.int/mediacentre/factsheets/typhoid/en/ Accessed May 2018.

TYPHIM Vi SmPC

Before you prescribe this vaccine please refer to the Prescribing information and SmPC links below.

TYPHIM Vi Prescribing information

View the TYPHIM Vi SmPC

Materials Ordering Online – Giving You Access to A Range Of Support Materials

Sanofi Pasteur is committed to providing you and your patients with a comprehensive range of support materials, including disease awareness patient leaflets and in-surgery display items.

• Simply visit https://sanofi.medisa.com

• Select the user group which best describes your role in your organisation

• Narrow your search by selecting the appropriate disease area

• Select which materials you would like to receive and how many

• Log-in or register to create an account

• Confirm your order

VISIT MEDISA

 

Date of preparation: November 2018 | SAGB.MIS.18.08.1323w